FNCHQ — Finch Therapeutics Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- $16.62m
- $0.58m
- $0.11m
Finch falls after Takeda ends bowel disease drug collaboration
Brief: Finch Therapeutics Regains Full Rights To FIN-524 And FIN-525 Targeted Microbiome Product Candidates In Development For IBD
Brief: Finch Therapeutics Provides Corporate Updates, Reports Q2 Results
U.S. STOCKS ON THE MOVE-Tesla, Target, Five Below, Bilibili
Brief: Finch Therapeutics Group Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Brief: Finch Therapeutics Provides Corporate Update And Reports First Quarter 2022 Financial Results
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc
U.S. STOCKS ON THE MOVE-Boeing Co, Cowen Inc, Carter's Inc
U.S. STOCKS ON THE MOVE-Phillips 66, Amazon.com Inc, Abbvie Inc
Finch Therapeutics up as FDA lifts clinical hold on bacterial infection therapy
U.S. STOCKS ON THE MOVE-Tesla Inc, LianBio, Intel Corp
Brief: Finch Therapeutics Announces Removal Of FDA Clinical Hold On CP101 IND
Brief: Finch Expects To Incur $1.1 Million In Costs As Result Of Restructuring
Brief: Finch Plans To Reduce Workforce By 20%
U.S. RESEARCH ROUNDUP- Albemarle, Okta, Walgreens
Brief: Finch Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:53 AM
U.S. STOCKS ON THE MOVE-Hewlett Packard, Pfizer, coal stocks